Inhibitory Effect of the Oral Administration of Bifidobacteria on Norfloxacin-Induced Verotoxin Production in Germ-Free Mice Infected with Escherichia coli O157:H7

• KOBAYASHI Intetsu

  Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories

• MURAOKA Hiroe

  Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories

• MATSUZAKI Kaoru

  Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories

• SAIKA Takeshi

  Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories

• NISHIDA Minoru

  Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories

• AKITA Hironobu

  Department of Pediatrics, St. Marianna University, Yokohama City Seibu Hospital

• IWATA Satoshi

  Department of Pediatrics, Kasumigaura National Hospital

• SATO Yoshitake

  Ota General Hospital

• SUNAKAWA Keisuke

  Department of Infectious Disease, School of Medicine, Kitasato University

収録刊行物

• Bioscience and microflora

  Bioscience and microflora 19 (1), 27-33, 2000-04-01

キーワード

• bifidobacteria
• germ-free mouse
• Escherichia coli O157:H7
• verotoxin
• inhibitory effect

詳細情報

• CRID: 1572824500885220608
• NII論文ID: 10026973956
• NII書誌ID: AA1108739X
• ISSN: 13421441
• 本文言語コード: en
• データソース種別:
  • CiNii Articles